1. The future of Health Care, the Digitisation of the Medtech Industry and Regulatory Update
Mark Steedman, PhD
4th December 2018

2. About us Publications www.deloitte.co.uk/centreforhealthsolutions
Established in 2011, the Centre is the independent research arm of Deloitte LLP’s healthcare and life sciences practices. Its role is to inform stakeholders across health care and life sciences about emerging trends, challenges, opportunities and examples of good practice. Using primary and secondary research and rigorous analysis to drive unique perspectives, the Centre seeks to be a trusted source for relevant, timely and reliable insights.
blogs.deloitte.co.uk/health/
Publications

3. Global health care spending
is projected to reach
$8.7 trillion by 2020
Up from $7 trillion in 2015
Why?
Aging and increasing populations
Emerging market expansion
Number of people aged over 65 has increased to more than 656 million, or 11.5% of the total population
Advances in medical treatments
Rising labor costs
Why?
Spending is expected to continue to be uneven
Better medical care, people living longer
Health care spending per person by 2021
Falling infant mortality rate
Lowering rates of communicable diseases
Diabetes expected to rise to 642
million people by 2040 due to:
Rapid urbanization
Sedentary lifestyles
Changing diets
Rising obesity levels
$11,356
United States
$53
Pakistan

4. Life Sciences and Healthcare Predictions 2022
The future awakens
Life Sciences and Healthcare Predictions 2022

5. Six predictions for 2022 - both evolutionary and revolutionary1
The quantified self is alive and well: The genome generation is more informed and engaged in managing their own health 2
The culture in health care is transformed by digital technologies: Smart health care is delivering more cost-effective patient-centred care 3
The life sciences industry is industrialised: Advanced cognitive technologies have improved the productivity, speed and compliance of core processes 4
Data is the new health care currency: Artificial intelligence and real-world evidence are unlocking value in health data 5
The future of medicine is here and now: Exponential advances in life-extending and precision therapies are improving outcomes 6
New entrants are disrupting health care: The boundaries between stakeholders have become increasingly blurred

6. The quantified self is alive and well1
The quantified self is alive and well
In 2022
The genome generation is more informed and engaged in managing their own health
Evidence from today
A 3-month programme to help you lose weight and change your lifestyle behaviours

7. The culture in health care is transformed by digital technologies2
The culture in health care is transformed by digital technologies
In 2022
Smart health care is delivering more cost-effective patient-centred care
Evidence from today
Mercy Virtual Care Center
In 2017, Mercy enabled 1300 ICU patients who otherwise would have been expected to die, to return home, saving $50 million in health care costs.

8. The life sciences industry is industrialised3
The life sciences industry is industrialised
In 2022
Advanced cognitive technologies have improved productivity, speed and compliance of core processes
Evidence from today
A ‘Contract in a Day’ project optimises clinical contract cycles to enhance relationships with investigational sites % reduction in effort to execute a contract cycle time down from around 8 weeks to 1-10 days
Three phases of industrialisation are transforming the productivity in knowledge-based organisations

9. Data is the new health care currency4
Data is the new health care currency
In 2022
Artificial intelligence and real-world evidence are unlocking value in health data
Evidence from today
Over the past five years, the Broad Institute has been the largest producer of human genomic information in the world, producing data at a rate of one 30X human whole genome every 12 minutes. The group has processed more than 1.5 million samples from more than 1400 groups in over 50 countries.

10. The future of medicine is here and now5
The future of medicine is here and now
In 2022
Exponential advances in life-extending and precision therapies are improving outcomes
Evidence from today
CAR-T cell therapy marks a fundamental shift in cancer therapy
Using CAR-T therapies to treat blood malignancies has shown response rates as high as per cent, but further research is required to see if the technology will have similar success in treating solid tumours.
Market forecasts estimate that the global CAR-T market will reach $10 billion within years, with a further future market potential of $ billion.

11. 6
New entrants are disrupting health care
In 2022
The boundaries between stakeholders have become increasingly blurred
Evidence from today
Tech giants are moving into health care
Amazon is said to be launching a new health care lab called 1492, focusing on improving interoperability and building out its Alexa voice assistant product suite to address health-related use cases
The Apple Watch®, CareKit®, and ResearchKit® initiatives are being used for research into chronic diseases and population health
23andMe and Google X research labs’ machine learning subsidiary DeepMind are expanding into R&D.

12. Conclusion
Across all of six predictions there are three key enablers that are critical to the realisation of the prediction and will impact the pace of change:
Adoption of new technology
Acquisition of appropriate skills and talent
A new approach to regulation
Adopting these enablers should see the life sciences and health care industries survive and thrive.

13. Medtech and the Internet of Medical Things
How connected medical devices are transforming health care

14. Report introduction IoMT ecosystem
Our report focuses on how the IoMT is transforming medtech’s role in health care and the impact of the increased use of connected medical devices on medtech companies’ business and operating models.

15. Forecast by geography and component
The IoMT market
What is the current and future market size?
Forecast by geography and component

16. Challenges and opportunities for medtech
The 8 key systemic challenges and opportunities facing the medtech industry
Challenges and opportunities for medtech
improving the adoption of medical technology at scale
developing an in-depth understanding of end users
developing new funding, business and operating models
understanding interoperability requirements
maintaining cybersecurity
successfully navigating regulatory change
attracting digital talent and building digital capability
maintaining trust in a digital age

17. Medtech’s role in transforming health care
Collaboration
Devices that benefit both patients and hospital providers
Advanced analytics
Joining the dots between connected medical devices and health care IT
Business model transformation

18. A bold future for life sciences regulation
Predictions 2025

19. Prediction 1: Regulators are globally aligned and coordinated

20. Prediction 2: Regulatory relationships are based on a ‘win-win’ approach

21. Prediction 3: Regulators successfully balance rapid assessment of innovation with real-time regulation

22. Prediction 4: A technology-enabled approach is driving the productivity and quality of regulation